Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether women (a) known and (b) suspected to have exposure to diethylstilbestrol in utero are eligible for enhanced cancer screening.

Yes, women who believe they have been exposed to diethylstilbestrol (DES) in utero are eligible for enhanced cancer screening. The NHS Cervical Screening Programme guidance reminds providers that these women are eligible for routine cervical screening and states that local arrangements should be made for the follow up of women who have been exposed to DES and who have the stigmata of DES exposure. This is usually via annual colposcopy.